Decriminalized in some states, psilocybin—an illegal ‘Class 1’ drug—is going through a revival of sorts. Some lawyers have sued the DEA to allow a physician to gain access to the drug to help cancer patients. According to clinical psychotherapy trials, the psychedelic drug eases depression in cancer patients.
Standards prohibiting synthesized drugs, monitoring sale limits, and prescribed production methods similar to that of medical marijuana will limit recreational usage and promote medical usage of these drugs.
